[Results of clinical trial of Ro-4-6270 in depressive-anxiety states].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000639:Amitriptyline / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy*; D001008:Anxiety Disorders / Q000188:drug therapy*; D001714:Bipolar Disorder / Q000188:drug therapy*; D002707:Chlordiazepoxide / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007046:Hysteria / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy*; D010698:Phobic Disorders / Q000188:drug therapy*; D011602:Psychophysiologic Disorders / Q000188:drug therapy*
D000639:Amitriptyline; D002707:Chlordiazepoxide
Risultati della sperimentazione clinica con Ro 4-6270 negli stati depressive-ansiosi.